Cargando…
Reply to “Benralizumab as a First-line Treatment for ABPA: Is It Really Indicated?”
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Japanese Society of Internal Medicine
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381187/ https://www.ncbi.nlm.nih.gov/pubmed/33583909 http://dx.doi.org/10.2169/internalmedicine.6952-20 |
| _version_ | 1783741319553744896 |
|---|---|
| author | Matsuura, Hiroaki Fujiwara, Keiichi Omori, Hiroki Onishi, Kiriko Kuribayashi, Tadahiro Mitsumune, Sho Takigawa, Yuki Kudo, Kenichiro Sato, Akiko Sato, Ken Shibayama, Takuo |
| author_facet | Matsuura, Hiroaki Fujiwara, Keiichi Omori, Hiroki Onishi, Kiriko Kuribayashi, Tadahiro Mitsumune, Sho Takigawa, Yuki Kudo, Kenichiro Sato, Akiko Sato, Ken Shibayama, Takuo |
| author_sort | Matsuura, Hiroaki |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8381187 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | The Japanese Society of Internal Medicine |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-83811872021-08-30 Reply to “Benralizumab as a First-line Treatment for ABPA: Is It Really Indicated?” Matsuura, Hiroaki Fujiwara, Keiichi Omori, Hiroki Onishi, Kiriko Kuribayashi, Tadahiro Mitsumune, Sho Takigawa, Yuki Kudo, Kenichiro Sato, Akiko Sato, Ken Shibayama, Takuo Intern Med Letters to the Editor The Japanese Society of Internal Medicine 2021-02-15 2021-08-01 /pmc/articles/PMC8381187/ /pubmed/33583909 http://dx.doi.org/10.2169/internalmedicine.6952-20 Text en Copyright © 2021 by The Japanese Society of Internal Medicine https://creativecommons.org/licenses/by-nc-nd/4.0/The Internal Medicine is an Open Access journal distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Letters to the Editor Matsuura, Hiroaki Fujiwara, Keiichi Omori, Hiroki Onishi, Kiriko Kuribayashi, Tadahiro Mitsumune, Sho Takigawa, Yuki Kudo, Kenichiro Sato, Akiko Sato, Ken Shibayama, Takuo Reply to “Benralizumab as a First-line Treatment for ABPA: Is It Really Indicated?” |
| title | Reply to “Benralizumab as a First-line Treatment for ABPA: Is It Really Indicated?” |
| title_full | Reply to “Benralizumab as a First-line Treatment for ABPA: Is It Really Indicated?” |
| title_fullStr | Reply to “Benralizumab as a First-line Treatment for ABPA: Is It Really Indicated?” |
| title_full_unstemmed | Reply to “Benralizumab as a First-line Treatment for ABPA: Is It Really Indicated?” |
| title_short | Reply to “Benralizumab as a First-line Treatment for ABPA: Is It Really Indicated?” |
| title_sort | reply to “benralizumab as a first-line treatment for abpa: is it really indicated?” |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381187/ https://www.ncbi.nlm.nih.gov/pubmed/33583909 http://dx.doi.org/10.2169/internalmedicine.6952-20 |
| work_keys_str_mv | AT matsuurahiroaki replytobenralizumabasafirstlinetreatmentforabpaisitreallyindicated AT fujiwarakeiichi replytobenralizumabasafirstlinetreatmentforabpaisitreallyindicated AT omorihiroki replytobenralizumabasafirstlinetreatmentforabpaisitreallyindicated AT onishikiriko replytobenralizumabasafirstlinetreatmentforabpaisitreallyindicated AT kuribayashitadahiro replytobenralizumabasafirstlinetreatmentforabpaisitreallyindicated AT mitsumunesho replytobenralizumabasafirstlinetreatmentforabpaisitreallyindicated AT takigawayuki replytobenralizumabasafirstlinetreatmentforabpaisitreallyindicated AT kudokenichiro replytobenralizumabasafirstlinetreatmentforabpaisitreallyindicated AT satoakiko replytobenralizumabasafirstlinetreatmentforabpaisitreallyindicated AT satoken replytobenralizumabasafirstlinetreatmentforabpaisitreallyindicated AT shibayamatakuo replytobenralizumabasafirstlinetreatmentforabpaisitreallyindicated |